Head of Pandemic Task Force discusses what a third vaccine option could mean

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

ST. LOUIS – More doses of the COVID vaccine are arriving in the St. Louis region each week and we may soon have a third vaccine from Johnson & Johnson.

The FDA says the efficacy of the J&J vaccine against moderate to severe/critical COVID-19 across all geographic areas was 66.9% at least 14 days after the single-dose vaccination and 66.1% at least 28 days after vaccination.

FOX 2 medical reporter Dan Gray speaks with Dr. Alex Garza, the head of the St. Louis Metropolitan Pandemic Task Force, to get his reaction to these new developments and discuss what this could mean for us in St. Louis.

Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.


Latest News

More News